In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes

Functionalized liposomes are among the most promising antineoplastic agents delivery vehicles. Contemporaneous to their accretion at the tumor site, they need to be potentiated to release their cargo using a suitable triggering modality. In this work, targeted DOX-loaded stealth liposomes were synth...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Abuwatfa, Waad Hussein (author)
مؤلفون آخرون: Paul, Vinod (author), AlSawaftah, Nour Majdi (author), Farooq, Afifa (author), Awad, Nahid S. (author), Husseini, Ghaleb (author)
التنسيق: article
منشور في: 2022
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/11073/25062
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513442028716032
author Abuwatfa, Waad Hussein
author2 Paul, Vinod
AlSawaftah, Nour Majdi
Farooq, Afifa
Awad, Nahid S.
Husseini, Ghaleb
author2_role author
author
author
author
author
author_facet Abuwatfa, Waad Hussein
Paul, Vinod
AlSawaftah, Nour Majdi
Farooq, Afifa
Awad, Nahid S.
Husseini, Ghaleb
author_role author
dc.creator.none.fl_str_mv Abuwatfa, Waad Hussein
Paul, Vinod
AlSawaftah, Nour Majdi
Farooq, Afifa
Awad, Nahid S.
Husseini, Ghaleb
dc.date.none.fl_str_mv 2022-11-01T05:55:37Z
2022-11-01T05:55:37Z
2022
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv Abuwatfa, W.; Paul, V.; AlSawaftah, N.; Farooq, A.; Awad, N.; Husseini, G.; In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes. Journal of Biomedical Nanotechnology, 2022, Vol. 18, 1–12. https://doi.org/10.1166/jbn.2022.3409.
1550-7041
http://hdl.handle.net/11073/25062
10.1166/jbn.2022.3409
dc.language.none.fl_str_mv en_US
dc.publisher.none.fl_str_mv American Scientific Publishers
dc.relation.none.fl_str_mv https://doi.org/10.1166/jbn.2022.3409
dc.subject.none.fl_str_mv Human Serum Albumin (HSA)
Liposomes
Low-Frequency Ultrasound (LFUS)
Controlled Release
Cell Viability
dc.title.none.fl_str_mv In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
dc.type.none.fl_str_mv Peer-Reviewed
Postprint
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Functionalized liposomes are among the most promising antineoplastic agents delivery vehicles. Contemporaneous to their accretion at the tumor site, they need to be potentiated to release their cargo using a suitable triggering modality. In this work, targeted DOX-loaded stealth liposomes were synthesized and functionalized with Human Serum Albumin (HSA) to target the overexpressed HSA receptors (HSA-Rs). The effects of low-frequency ultrasound (LFUS) in inducing DOX release from the synthesized liposomes were investigated in vitro. DOX release increased with the increasing power density of the ultrasound. HSA conjugation to the liposomes increased their sensitivity to LFUS. Furthermore, HSA conjugation also enhanced the liposome’s cytotoxic activity and uptake by the cancer cells overexpressing HSA-Rs. This cytotoxic activity and cellular uptake were further enhanced by triggering drug release from those targeted liposomes using LFUS. Combining HSA-targeted liposomes with LFUS is a promising approach in drug delivery.
format article
id aus_d9e6258240b79450e9e87e83d809e091
identifier_str_mv Abuwatfa, W.; Paul, V.; AlSawaftah, N.; Farooq, A.; Awad, N.; Husseini, G.; In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes. Journal of Biomedical Nanotechnology, 2022, Vol. 18, 1–12. https://doi.org/10.1166/jbn.2022.3409.
1550-7041
10.1166/jbn.2022.3409
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/25062
publishDate 2022
publisher.none.fl_str_mv American Scientific Publishers
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated LiposomesAbuwatfa, Waad HusseinPaul, VinodAlSawaftah, Nour MajdiFarooq, AfifaAwad, Nahid S.Husseini, GhalebHuman Serum Albumin (HSA)LiposomesLow-Frequency Ultrasound (LFUS)Controlled ReleaseCell ViabilityFunctionalized liposomes are among the most promising antineoplastic agents delivery vehicles. Contemporaneous to their accretion at the tumor site, they need to be potentiated to release their cargo using a suitable triggering modality. In this work, targeted DOX-loaded stealth liposomes were synthesized and functionalized with Human Serum Albumin (HSA) to target the overexpressed HSA receptors (HSA-Rs). The effects of low-frequency ultrasound (LFUS) in inducing DOX release from the synthesized liposomes were investigated in vitro. DOX release increased with the increasing power density of the ultrasound. HSA conjugation to the liposomes increased their sensitivity to LFUS. Furthermore, HSA conjugation also enhanced the liposome’s cytotoxic activity and uptake by the cancer cells overexpressing HSA-Rs. This cytotoxic activity and cellular uptake were further enhanced by triggering drug release from those targeted liposomes using LFUS. Combining HSA-targeted liposomes with LFUS is a promising approach in drug delivery.American University of SharjahAlJalila FoundationAl Qasimi FoundationPatient’s Friends CommitteeBiosciences and Bioengineering Research Institute, GCCTakamulTechnology Innovation Pioneer-Healthcare (TIP) ProgramSheikh Hamdan Award for Medical SciencesFriends of Cancer Patients (FoCP)Dana Gas Endowed Chair for Chemical EngineeringAmerican Scientific Publishers2022-11-01T05:55:37Z2022-11-01T05:55:37Z2022Peer-ReviewedPostprintinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfAbuwatfa, W.; Paul, V.; AlSawaftah, N.; Farooq, A.; Awad, N.; Husseini, G.; In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes. Journal of Biomedical Nanotechnology, 2022, Vol. 18, 1–12. https://doi.org/10.1166/jbn.2022.3409.1550-7041http://hdl.handle.net/11073/2506210.1166/jbn.2022.3409en_UShttps://doi.org/10.1166/jbn.2022.3409oai:repository.aus.edu:11073/250622024-08-22T12:05:12Z
spellingShingle In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
Abuwatfa, Waad Hussein
Human Serum Albumin (HSA)
Liposomes
Low-Frequency Ultrasound (LFUS)
Controlled Release
Cell Viability
status_str publishedVersion
title In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
title_full In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
title_fullStr In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
title_full_unstemmed In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
title_short In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
title_sort In Vitro Evaluation of Ultrasound Effectiveness in Controlling Doxorubicin Release from Albumin-Conjugated Liposomes
topic Human Serum Albumin (HSA)
Liposomes
Low-Frequency Ultrasound (LFUS)
Controlled Release
Cell Viability
url http://hdl.handle.net/11073/25062